GlassScriptPrepare for your visit
Ankit D Rathod
Nuclear Cardiology · Fresno, CA · NPI 1073751962
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,155.54
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Siemens Medical Solutions USA, INC. $1,764.04
- Amgen INC. $165.04
- United Therapeutics Corporation $98.32
- E.R. Squibb & Sons, L.L.C. $41.94
- Actelion Pharmaceuticals US, INC. $35.37
- Lexicon Pharmaceuticals, INC. $20.69
Drugs and devices associated with these payments
Repatha Uptravi Opsumit Camzyos Inpefa Entresto
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ankit Rathod listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/650294/ankit-d-rathod